Review



nonlinear regression sigmoidal dose response  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc nonlinear regression sigmoidal dose response
    Nonlinear Regression Sigmoidal Dose Response, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression sigmoidal dose response/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression sigmoidal dose response - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    90
    GraphPad Software Inc nonlinear regression sigmoidal dose response
    Nonlinear Regression Sigmoidal Dose Response, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression sigmoidal dose response/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression sigmoidal dose response - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonlinear regression curve fitting package (sigmoidal dose–response)
    IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. <xref ref-type= S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="250" height="auto" />
    Nonlinear Regression Curve Fitting Package (Sigmoidal Dose–Response), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression curve fitting package (sigmoidal dose–response)/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression curve fitting package (sigmoidal dose–response) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonlinear regression sigmoidal dose-response model variable slope
    IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. <xref ref-type= S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="250" height="auto" />
    Nonlinear Regression Sigmoidal Dose Response Model Variable Slope, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression sigmoidal dose-response model variable slope/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression sigmoidal dose-response model variable slope - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonlinear regression sigmoidal dose response graphpad prism 6
    IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. <xref ref-type= S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="250" height="auto" />
    Nonlinear Regression Sigmoidal Dose Response Graphpad Prism 6, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression sigmoidal dose response graphpad prism 6/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression sigmoidal dose response graphpad prism 6 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonlinear regression sigmoidal dose-response (variable slope) curve fit
    IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. <xref ref-type= S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="250" height="auto" />
    Nonlinear Regression Sigmoidal Dose Response (Variable Slope) Curve Fit, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression sigmoidal dose-response (variable slope) curve fit/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression sigmoidal dose-response (variable slope) curve fit - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier



    90
    GraphPad Software Inc nonlinear-regression sigmoidal dose-response curve model within the graphpad prism software
    IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. <xref ref-type= S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="250" height="auto" />
    Nonlinear Regression Sigmoidal Dose Response Curve Model Within The Graphpad Prism Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear-regression sigmoidal dose-response curve model within the graphpad prism software/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear-regression sigmoidal dose-response curve model within the graphpad prism software - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonlinear regression analysis using the sigmoidal dose–response model with variable slope
    IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. <xref ref-type= S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="250" height="auto" />
    Nonlinear Regression Analysis Using The Sigmoidal Dose–Response Model With Variable Slope, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonlinear regression analysis using the sigmoidal dose–response model with variable slope/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    nonlinear regression analysis using the sigmoidal dose–response model with variable slope - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested." width="100%" height="100%">

    Journal: Scientific Reports

    Article Title: Hyperpolarized [1- 13 C]pyruvate NMR spectroscopy reveals transition of tumor energy metabolism in microscale multicellular spheroids

    doi: 10.1038/s41598-025-03454-1

    Figure Lengend Snippet: IC 50 and IC 90 values (μM) of anti-tumor drugs for monolayer and spheroid-cultured cells in a 96-well format (Fig. S2 , n = 3). Each cell culture was performed at 37 °C in an atmosphere containing 5% CO 2 , and treated with various concentrations of drugs for 48 h. Cell viability was assessed using the MTS assay reagent (Promega). Data were analyzed using a nonlinear regression curve-fitting package in Prism 4 (GraphPad Software Inc.) (Fig. S2 ). The drugs tested included: docetaxel, a mitotic inhibitor; irinotecan, a topoisomerase I inhibitor; 5-fluorouracil (5-FU), a thymidylate synthase inhibitor; sunitinib, a multi-receptor tyrosine kinase (RTK) inhibitor; tirapazamine, a hypoxia-activated prodrug; and FX11, a lactate dehydrogenase inhibitor. Radial organization of each cell on the spheroidal culture dish (IWAKI) conferred resistance to the most of drugs tested.

    Article Snippet: Cell viability in each drug concentration was plotted (Fig. ), and the sigmoidal dose–response curve was calculated using a nonlinear regression curve fitting package (sigmoidal dose–response) in Prism 4 (GraphPad Software Inc., La Jolla, CA).

    Techniques: Cell Culture, MTS Assay, Software